Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study
Authors
Keywords
-
Journal
Obesity
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-03
DOI
10.1002/oby.23869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity among Latinx people in the United States: A review
- (2023) José Orlando Alemán et al. Obesity
- Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the U.S.
- (2021) Karine Suissa et al. DIABETES OBESITY & METABOLISM
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coverage of obesity and obesity disparities on American Board of Medical Specialties (ABMS) examinations
- (2021) Siddharth Yarlagadda et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities
- (2021) Rozalina G. McCoy et al. DIABETES CARE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
- (2021) Michael Fang et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Commission classifies obesity as a chronic disease
- (2021) Talha Burki Lancet Diabetes & Endocrinology
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications
- (2021) W Timothy Garvey JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
- (2021) Ildiko Lingvay et al. LANCET
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- New directions in incidence and prevalence of diagnosed diabetes in the USA
- (2019) Stephen R Benoit et al. BMJ Open Diabetes Research & Care
- Obesity education in medical schools, residencies, and fellowships throughout the world: a systematic review
- (2019) Marissa R. Mastrocola et al. INTERNATIONAL JOURNAL OF OBESITY
- Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
- (2019) David R. Saxon et al. Obesity
- Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study
- (2018) Guifeng Xu et al. BMJ-British Medical Journal
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
- (2017) G Gomez et al. INTERNATIONAL JOURNAL OF OBESITY
- National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care
- (2017) Donovan T. Maust et al. JOURNAL OF CLINICAL PSYCHIATRY
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
- (2016) W. Timothy Garvey et al. Endocrine Practice
- Regarding Obesity as a Disease
- (2016) Theodore K. Kyle et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s
- (2016) Catherine E. Thomas et al. Obesity
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
- (2015) Juan Pablo Domecq et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antipsychotic Treatment of Adults in the United States
- (2015) Mark Olfson et al. JOURNAL OF CLINICAL PSYCHIATRY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
- (2013) R. A. DeFronzo et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started